Literature DB >> 23700976

Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia.

Yingqi Shao, Xingxin Li, Jun Shi, Meili Ge, Jinbo Huang, Zhendong Huang, Jing Zhang, Neng Nie, Yizhou Zheng.   

Abstract

Entities:  

Keywords:  cyclosporin; levamisole; refractory; relapsed; severe aplastic anaemia

Mesh：

Substances：

Year:  2013        PMID： 23700976     DOI： 10.1111/bjh.12383

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.

Authors:  Min Wang; Xingxin Li; Jun Shi; Yingqi Shao; Meili Ge; Jinbo Huang; Zhendong Huang; Jing Zhang; Neng Nie; Yizhou Zheng
Journal:  Int J Hematol       Date:  2015-06-14       Impact factor: 2.490

Review 2.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

3.  Levamisole Suppresses CD4+ T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways.

Authors:  Jiali Wang; Jia Liu; Mingyang Wang; Fei Zhao; Meili Ge; Li Liu; Erlie Jiang; Sizhou Feng; Mingzhe Han; Xiaolei Pei; Yizhou Zheng
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.